"We really should have a system that is patient-centric, physician-led, and professionally managed, but in a cost-effective way," Rick Snyder, MD, said.

Researchers tracked years of data, noting that strokes and other neurological adverse events reduce a patient's odds of survival.  

The product at the heart of this recall is a dietary supplement taken to boost energy and performance when exercising. The FDA previously warned the public not to take it due to the potential side effects. 

Cleerly and Clear Heart and Lung Imaging partnered to drive a cardiac-capable mobile CT scanner across Arizona, Louisiana, Georgia and Florida. Their goals were to evaluate patients in underserved parts of the United States and collect data for an ongoing clinical trial.

Newsweek and Statista have shared their 2027 list of the world’s top 300 hospitals for cardiology. Nine of the top 20 are based in the United States.

The studies all answer key clinical questions, highlighting a variety of new technologies, drugs and techniques. 

Wearable trackers found that PE patients were more active if they underwent mechanical thrombectomy than if they were just put on anticoagulation therapy alone.

The overall mortality rate for U.S. patients with cardiovascular disease has improved significantly in recent years. At the same time, however, care gaps remain that must be addressed.

Johnson & Johnson is selling key assets related to its Laminar program to a new startup, Jaguar LAA. This comes less than three years after Johnson & Johnson acquired Laminar for $400 million. 

Eating four to six servings of whole-grain foods per day is associated with multiple cardiovascular benefits, according to a new meta-analysis of dozens of clinical trials. 

The team behind this new meta-analysis reviewed data from more than 24,000 patients with a mean age of nearly 65 years old. They identified several benefits to choosing intravascular imaging guidance during PCI over traditional angiography alone.

The agency is warning hospitals that failing to publicly post the prices they charge for services will not only elicit the ire of HHS.

Delays in diagnostic resolution—following an abnormal screening mammogram—can lead to patient anxiety, later-stage cancer diagnoses, and poorer breast cancer survival.